Congratulations to the Cardiology Team who performed a new procedure in Cath Lab on Friday 27th August.
The Cardiology Team performed MitraClip™Transcatheter Mitral Valve Repair (TMVr) procedure which is a life-changing TMVr Therapy for select patients with mitral regurgitation. Treating mitral regurgitation with MitraClip Therapy can mean an improved quality of life and relief from the symptoms of heart failure. Clinical studies show intervention with MitraClip transcatheter mitral valve repair therapy safely reduces mitral regurgitation in patients despite being elderly with a high rate of serious comorbilities, or suffering from heart failure.
MitraClip™ is the world’s first transcatheter mitral valve repair (TMVr) therapy that delivers a minimally invasive treatment option for select patients with primary or secondary mitral regurgitation (MR) who would otherwise go untreated. With more than 17years of clinical experience and over 100,000 patients treated worldwide, MitraClip™ is a well-established procedure with proven safety and survival, and durable clinical outcomes.